These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 39171923
1. In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512. Capitani V, Arcari G, Ambrosi C, Scribano D, Ceparano M, Polani R, De Francesco A, Raponi G, Ceccarelli G, Villari P, Palamara AT, Marzuillo C, Carattoli A. mSphere; 2024 Sep 25; 9(9):e0042324. PubMed ID: 39171923 [Abstract] [Full Text] [Related]
2. A large-scale surveillance revealed that KPC variants mediated ceftazidime-avibactam resistance in clinically isolated Klebsiella pneumoniae. Qiao S, Xin S, Zhu Y, Zhao F, Wu H, Zhang J, Yao B, Yu Y, Fu Y, Jiang Y, Xie X, Zhang J. Microbiol Spectr; 2024 Aug 06; 12(8):e0025824. PubMed ID: 38958437 [Abstract] [Full Text] [Related]
3. In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam. Guzmán-Puche J, Pérez-Nadales E, Pérez-Vázquez M, Causse M, Gracia-Ahufinger I, Mendez-Natera A, Allalou-Ruiz Y, Elías C, Oteo-Iglesias J, Torre-Cisneros J, Martínez-Martínez L. Int J Antimicrob Agents; 2022 Feb 06; 59(2):106524. PubMed ID: 35038557 [Abstract] [Full Text] [Related]
4. Molecular Mechanisms Driving the In Vivo Development of KPC-71-Mediated Resistance to Ceftazidime-Avibactam during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections. Li X, Ke H, Wu W, Tu Y, Zhou H, Yu Y. mSphere; 2021 Dec 22; 6(6):e0085921. PubMed ID: 34935448 [Abstract] [Full Text] [Related]
5. A novel KPC-166 in ceftazidime/avibactam resistant ST307 Klebsiella pneumoniae causing an outbreak in intensive care COVID Unit, Italy. Piazza A, Mattioni Marchetti V, Bielli A, Biffignandi GB, Piscopiello F, Giudici R, Tartaglione L, Merli M, Vismara C, Migliavacca R. J Microbiol Immunol Infect; 2024 Jun 22; 57(3):457-469. PubMed ID: 38584042 [Abstract] [Full Text] [Related]
6. Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent Klebsiella pneumoniae. Shi Q, Shen S, Tang C, Ding L, Guo Y, Yang Y, Wu S, Han R, Yin D, Hu F. Emerg Microbes Infect; 2024 Dec 22; 13(1):2361007. PubMed ID: 38801099 [Abstract] [Full Text] [Related]
7. Ceftazidime-Avibactam Resistance Associated with Increased blaKPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae. Coppi M, Di Pilato V, Monaco F, Giani T, Conaldi PG, Rossolini GM. Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31964792 [Abstract] [Full Text] [Related]
8. Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient. Zhou J, Yan G, Tang C, Liu J, Fu P, Ding L, Yang W, Guo Y, Wang C, Lu G, Hu F. Int J Antimicrob Agents; 2024 Jun 24; 63(6):107163. PubMed ID: 38570018 [Abstract] [Full Text] [Related]
11. Reversion of KPC-114 to KPC-2 in ceftazidime-avibactam- resistant/meropenem-susceptible Klebsiella pneumoniae ST11 is related to low mutation rates. Pariona JGM, Vásquez-Ponce F, Becerra J, Martins-Gonçalves T, Pariona EMM, Madueño FT, Esposito F, V de Lima A, Mello Sampaio JL, Galhardo RS, Lincopan N. Microbiol Spectr; 2024 Oct 03; 12(10):e0117324. PubMed ID: 39190636 [Abstract] [Full Text] [Related]
15. Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments. Gaibani P, Bovo F, Bussini L, Lazzarotto T, Amadesi S, Bartoletti M, Viale P, Ambretti S. J Antimicrob Chemother; 2022 May 29; 77(6):1570-1577. PubMed ID: 35373297 [Abstract] [Full Text] [Related]
17. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. Zhang P, Shi Q, Hu H, Hong B, Wu X, Du X, Akova M, Yu Y. Clin Microbiol Infect; 2020 Jan 29; 26(1):124.e1-124.e4. PubMed ID: 31494252 [Abstract] [Full Text] [Related]
18. The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae. Zhang P, Hu H, Shi Q, Sun L, Wu X, Hua X, McNally A, Jiang Y, Yu Y, Du X. Antimicrob Agents Chemother; 2023 Mar 16; 67(3):e0127922. PubMed ID: 36794957 [Abstract] [Full Text] [Related]
19. Double blaKPC-2 copies quadrupled minimum inhibitory concentration of ceftazidime-avibactam in hospital-derived Klebsiella pneumoniae. Hu D, Wang S, Xu M, Zhang J, Luo X, Zhou W, Ma Q, Ma X. Microbiol Spectr; 2024 Aug 06; 12(8):e0033124. PubMed ID: 38984824 [Abstract] [Full Text] [Related]
20. KPC-2 allelic variants in Klebsiella pneumoniae isolates resistant to ceftazidime-avibactam from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97. Sanz MB, Pasteran F, de Mendieta JM, Brunetti F, Albornoz E, Rapoport M, Lucero C, Errecalde L, Nuñez MR, Monge R, Pennini M, Power P, Corso A, Gomez SA. Microbiol Spectr; 2024 Mar 05; 12(3):e0411123. PubMed ID: 38319084 [Abstract] [Full Text] [Related] Page: [Next] [New Search]